Eurofins Scientific SE
ERF
주식 순위
#1379
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
주가
$93.33
마지막 동기화: 2026-10-20
시가총액
$16.20B
변동 (1일)
-0.33%
변동 (1년)
28.73%
국가
LU
거래 Eurofins Scientific SE (ERF)
카테고리
Healthcare
Eurofins Scientific SE (ERF)의 발행 주식 수
June 2026 기준 발행 주식 수: 175.50M
Eurofins Scientific SE의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 175.50M입니다. December 2024 말 기준 회사는 190.60M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Eurofins Scientific SE (ERF)의 발행 주식 수 기록 (2002 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 175.50M | -2.50% |
| 2025 | 180.00M | -5.56% |
| 2024 | 190.60M | -1.19% |
| 2023 | 192.90M | 0.21% |
| 2022 | 192.50M | 0.52% |
| 2021 | 191.50M | 2.85% |
| 2020 | 186.20M | 4.61% |
| 2019 | 178.00M | 0.56% |
| 2018 | 177.00M | 3.51% |
| 2017 | 170.99M | 6.94% |
| 2016 | 159.90M | 4.57% |
| 2015 | 152.91M | 1.08% |
| 2014 | 151.27M | 0.89% |
| 2013 | 149.93M | 2.85% |
| 2012 | 145.77M | 1.77% |
| 2011 | 143.24M | 0.70% |
| 2010 | 142.24M | 0.29% |
| 2009 | 141.83M | 0.91% |
| 2008 | 140.55M | 1.09% |
| 2007 | 139.03M | 0.70% |
| 2006 | 138.06M | 0.96% |
| 2005 | 136.75M | 1.76% |
| 2004 | 134.38M | 2.03% |
| 2003 | 131.71M | 0.05% |
| 2002 | 131.64M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 371.00M | 111.40% |
US
|
|
| 705.30M | 301.88% |
US
|
|
| 143.28M | -18.36% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 60.68% |
US
|
